Mar 19,2022 Apexigen and Brookline Capital Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Immuno-oncology Company read more >>
Mar 09,2022 C4 Therapeutics Announces FDA Orphan Drug Designation for CFT8634 for the Treatment of Soft Tissue Sarcoma read more >>
Feb 04,2022 Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing read more >>
Jan 27,2022 Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics read more >>
Jan 18,2022 Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into the Clinics read more >>